Morocco ReportMorocco ReportMorocco Report
  • Automotive
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Luxury
  • News
  • More
    • Sports
    • Technology
    • Travel
Reading: Apollo Hospitals Unveils South Asia’s First ZAP-X, Transforming Brain Tumor Care
Share
Font ResizerAa
Font ResizerAa
Morocco ReportMorocco Report
Search
  • Automotive
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Luxury
  • News
  • More
    • Sports
    • Technology
    • Travel
© 2022 Morocco Report | All Rights Reserved
Home » Apollo Hospitals Unveils South Asia’s First ZAP-X, Transforming Brain Tumor Care
PR Newswire

Apollo Hospitals Unveils South Asia’s First ZAP-X, Transforming Brain Tumor Care

Published: March 11, 2024
Share
SHARE

NEW DELHI, March 11, 2024 /PRNewswire/ — Apollo Hospitals becomes the first hospital to introduce ZAP-X Gyroscopic Radiosurgery Platform, a significant milestone as the first in South Asia to introduce this ground-breaking technology. ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.

Prof. John R. Adler, Founder and CEO, Zap Surgical and Professor of Neurosurgery, Stanford School of Medicine and Dr Prathap Chandra Reddy, Founder Chairman, Apollo Hospitals Group at the launch of Zap-X Gyroscopic Radiosurgery Platform in New Delhi

This transformative technology redefines precision with minimal radiation exposure, enabling new standards in effectiveness and patient comfort. Unlike conventional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design, to direct radiosurgical beams from thousands of potential angles, accurately focusing radiation on the intended tumor or target. Moreover, traditional brain surgeries, lasting 3-4 hours, are replaced by ZAP-X’s single-session treatment of no more than 30 minutes, facilitating day-care procedures and allowing patients to return home post-treatment, unlike traditional surgeries requiring extended hospitalization and anesthesia. ZAP-X demonstrates high success, ensuring effective control and relief for various conditions with minimal side effects, achieving over 95% control rate in 10 years and an exceptional 99.4% control rate in 5 years for small, defined tumors. These proven clinical capabilities enable neurologists and neurosurgeons to treat various conditions with better accuracy and fewer side effects.

Dr Prathap Chandra Reddy, Founder Chairman, Apollo Hospitals Group said, “For four decades, Apollo Hospitals has pioneered healthcare, advancing exceptional care. We pledge to democratize technology, making it accessible to all citizens and global communities, elevating standards of brain tumor treatment and ensuring better quality of life. ZAP-X strengthens the battle against Non-Communicable Diseases, especially cancers with superior outcomes.”

Prof. John R. Adler, Founder and CEO, Zap Surgical and Professor of Neurosurgery, Stanford School of Medicine said, “Stereotactic radiosurgery is among the most important medical advancements of the past century. Eligible patients no longer must experience debilitating surgical resections, or potentially lose cognitive capacity by undergoing whole-brain radiotherapy. Instead, with ZAP-X radiosurgery, patients can now be quickly treated in an outpatient setting and often return to normal activities the same day with no incisions, and no pain.”

The Apollo Institute of Neurosciences pioneers neurological care in India and beyond, boasting advanced facilities and over 180,000 successful neurosurgeries. With smart technology, stroke protocols are revolutionized for faster, precise treatment. Supported by 300+ specialists, Apollo annually treats 25,000 patients. The unveiling of the ZAP-X platform reaffirms Apollo’s commitment to spearheading innovations that transform lives.

Photo – https://mma.prnewswire.com/media/2358764/Zap_X.jpg
Logo: https://mma.prnewswire.com/media/2358197/Apollo_Hospitals_Logo.jpg

Apollo_Hospitals_Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/apollo-hospitals-unveils-south-asias-first-zap-x-transforming-brain-tumor-care-302084679.html

You Might Also Like

Kenya Nut Company Installs First Commercial On-Site Green Ammonia System for Carbon-Free Fertilizer Production
Royal Commission for AlUla announces contractor and begins construction on Sharaan Resort and International Summit Centre
‘Ride For Unity’ Launches Flagship Rwanda Tour with Global Riders, ahead of UCI Road World Championships
Chinese Literature Giant Liu Zhenyun Comes to Nicosia Book Fest 2023, Sharing His Latest Translated Novels with Global Readers
World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
Share This Article
Facebook TwitterEmail Print
Previous Article Huawei Named a Leader in the 2024 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure, with Highest 3 in the "Ability to Execute"
Next Article UNIFRUTTI GROUP ACQUIRES BOMAREA AND AVOAMERICA PERU TO FURTHER STRENGTHEN ITS GLOBAL MULTI-FRUIT PLATFORM

Latest News

Northern Ontario wildfires trigger evacuations and closures
Northern Ontario wildfires trigger evacuations and closures
UN extends Red Sea attack reporting through January 2027
UN Extends Red Sea Attack Monitoring Through January 2027
Bangladesh floods kill 51 and affect one million people
Bangladesh floods kill 51 and affect one million people
India and Australia deepen ties across defence and energy
India and Australia deepen ties across defence and energy
Italy and GCC sign MoU to expand political cooperation
Italy and GCC sign MoU to expand political cooperation
Macron visit puts Syria reconstruction deals in focus
Macron visit puts Syria reconstruction deals in focus
© 2026 Morocco Report | All Rights Reserved
  • Home
  • Contact Us
Welcome Back!

Sign in to your account